Shu Ling Cheng
Chief Executive Officer bei DIAMOND BIOFUND INC.
Profil
Shu Ling Cheng was the founder of OncoHealth Corp.
(founded in 2009) and Neodiagnostic Labs, Inc. (founded in 2005) where she held the titles of Director & Chief Scientific Officer and Chief Scientific Officer, respectively.
She is currently the General Manager at Diamond BioFund Inc. Dr. Cheng's former positions include Principal at Eurofins DiscoverX Corp., Inc. and Thermo Fisher Co., and Deputy General Manager-Research & Development at Medeon Biodesign, Inc. Dr. Cheng's education includes a graduate degree from The Ohio State University, a doctorate from the University of Illinois, and an undergraduate degree from National Chung Hsing University.
Aktive Positionen von Shu Ling Cheng
| Unternehmen | Position | Beginn |
|---|---|---|
| DIAMOND BIOFUND INC. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Shu Ling Cheng
| Unternehmen | Position | Ende |
|---|---|---|
| Neodiagnostic Labs, Inc. | Founder | 01.01.2009 |
| MEDEON BIODESIGN, INC. | Chief Tech/Sci/R&D Officer | - |
| Thermo Fisher Co. | Corporate Officer/Principal | - |
Eurofins DiscoverX Corp., Inc.
 Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
OncoHealth Corp.
 OncoHealth Corp. BiotechnologyHealth Technology OncoHealth Corp. operates as a protein biomarker diagnostics company. It commercializes unique proprietary tests for cervical cancer and other cancers associated with human papillomavirus (HPV). The company was founded by Winnie H. Wan and Shuling Cheng in December on July 26, 2010 and is headquartered in Mountain View, CA. | Founder | - |
Ausbildung von Shu Ling Cheng
| The Ohio State University | Graduate Degree |
| University of Illinois | Doctorate Degree |
| National Chung Hsing University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MEDEON BIODESIGN, INC. | Electronic Technology |
| DIAMOND BIOFUND INC. | Finance |
| Private Unternehmen | 4 |
|---|---|
OncoHealth Corp.
OncoHealth Corp. BiotechnologyHealth Technology OncoHealth Corp. operates as a protein biomarker diagnostics company. It commercializes unique proprietary tests for cervical cancer and other cancers associated with human papillomavirus (HPV). The company was founded by Winnie H. Wan and Shuling Cheng in December on July 26, 2010 and is headquartered in Mountain View, CA. | Health Technology |
Eurofins DiscoverX Corp., Inc.
Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Health Technology |
| Thermo Fisher Co. | Miscellaneous |
| Neodiagnostic Labs, Inc. |
